TY - JOUR
T1 - Optimizing cellular immunity against HIV-1 Gag and preventing suppression by HIV-1 gp120
AU - van Montfort, Thijs
AU - Sanders, Rogier W.
PY - 2012
Y1 - 2012
N2 - SIV vaccination studies in monkeys have revealed that Env-directed antibodies are critical for protection against virus acquisition, whereas CD8(+) T-cell responses against the Gag and Pal proteins contribute to control of viremia postinfection. However, designing a vaccine that strongly activates both arms of the immune system, is challenging for a variety of reasons, one being interference of Gag and Env responses. Bockl et al. have studied how to optimize CD8 T-cell responses against Gag, Pol and Nef in the presence of Env co-vaccination. Although Env coadministration suppressed anti-Gag CD8(+) responses, this effect could be counteracted by adjusting the molar ratio of the vaccines and by spatial or temporal separation of the Gag and Env antigens. These results demonstrate that optimal induction of antiviral CD8(+) responses requires careful optimization of vaccine design, composition and administration
AB - SIV vaccination studies in monkeys have revealed that Env-directed antibodies are critical for protection against virus acquisition, whereas CD8(+) T-cell responses against the Gag and Pal proteins contribute to control of viremia postinfection. However, designing a vaccine that strongly activates both arms of the immune system, is challenging for a variety of reasons, one being interference of Gag and Env responses. Bockl et al. have studied how to optimize CD8 T-cell responses against Gag, Pol and Nef in the presence of Env co-vaccination. Although Env coadministration suppressed anti-Gag CD8(+) responses, this effect could be counteracted by adjusting the molar ratio of the vaccines and by spatial or temporal separation of the Gag and Env antigens. These results demonstrate that optimal induction of antiviral CD8(+) responses requires careful optimization of vaccine design, composition and administration
U2 - https://doi.org/10.1586/ERV.12.102
DO - https://doi.org/10.1586/ERV.12.102
M3 - Article
C2 - 23176650
SN - 1476-0584
VL - 11
SP - 1175
EP - 1177
JO - Expert Review of Vaccines
JF - Expert Review of Vaccines
IS - 10
ER -